Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 286 AL 300

Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future Perspective

Grover P, Rohilla S, Bhardwaj M, Mehta L, Malhotra A.

Curr Top Med Chem. 2023;23(13):1221-1259. doi: 10.2174/1568026623666230406084315.

Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications

Xu Y, Zheng F, Zhong Q, Zhu Y.

J Alzheimers Dis. 2023;92(4):1173-1198. doi: 10.3233/JAD-230002.

Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial

Berry DA, Dhadda S, Kanekiyo M, Li D, Swanson CJ, Irizarry M, Kramer LD, Berry SM.

JAMA Netw Open. 2023 Apr 3;6(4):e237230. doi: 10.1001/jamanetworkopen.2023.7230.

The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies

Lozupone M, Dibello V, Sardone R, Castellana F, Zupo R, Lampignano L, Bortone I, Stallone R, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Panza F.

Expert Opin Drug Discov. 2023 May;18(5):515-526. doi: 10.1080/17460441.2023.2200245. Epub 2023 Apr 11.

The future of alzheimer disease immunotherapies in Saudi Arabia: Consensus statement of the Saudi Chapter of Cognitive and Behavioral Neurology

Tayeb HO, Khallaf RA, Muayqil TA, Alkeridy WA, Alibrahim FS, Alfaify OA, Qadi N, Tarazi FI.

Neurosciences (Riyadh). 2023 Apr;28(2):77-84. doi: 10.17712/nsj.2023.2.20220133.

Exploring the Causal Relationship Between Telomere Biology and Alzheimer's Disease

Kuan XY, Fauzi NSA, Ng KY, Bakhtiar A.

Mol Neurobiol. 2023 Aug;60(8):4169-4183. doi: 10.1007/s12035-023-03337-4. Epub 2023 Apr 12.

Multifaceted Roles of Aquaporins in the Pathogenesis of Alzheimer's Disease

Yamada K.

Int J Mol Sci. 2023 Mar 31;24(7):6528. doi: 10.3390/ijms24076528.

Vitamin D and Its Analogues: From Differences in Molecular Mechanisms to Potential Benefits of Adapted Use in the Treatment of Alzheimer's Disease

Thiel A, Hermanns C, Lauer AA, Reichrath J, Erhardt T, Hartmann T, Grimm MOW, Grimm HS.

Nutrients. 2023 Mar 30;15(7):1684. doi: 10.3390/nu15071684.

A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease

Bai H, Naj AC, Benchek P, Dumitrescu L, Hohman T, Hamilton-Nelson K, Kallianpur AR, Griswold AJ, Vardarajan B, Martin ER, Beecham GW, Below JE, Schellenberg G, Mayeux R, Farrer L, Pericak-Vance MA, Haines JL, Bush WS; Alzheimer's Disease Genetics Consortium.

Alzheimers Dement. 2023 Nov;19(11):4886-4895. doi: 10.1002/alz.13050. Epub 2023 Apr 12.

Structural polymorphism and cytotoxicity of brain-derived β-amyloid extracts

Al Adem K, Lee S.

Protein Sci. 2023 May;32(5):e4639. doi: 10.1002/pro.4639.

Chronic effects of inflammation on tauopathies

Langworth-Green C, Patel S, Jaunmuktane Z, Jabbari E, Morris H, Thom M, Lees A, Hardy J, Zandi M, Duff K.

Lancet Neurol. 2023 May;22(5):430-442. doi: 10.1016/S1474-4422(23)00038-8.

Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer's disease?

Petrovskaya A, Tverskoi A, Medvedeva A, Nazarova M.

Commun Biol. 2023 Apr 14;6(1):416. doi: 10.1038/s42003-023-04717-1.

Advances in proteomic phenotyping of microglia in neurodegeneration

Sunna S, Bowen CA, Ramelow CC, Santiago JV, Kumar P, Rangaraju S.

Proteomics. 2023 Jul;23(13-14):e2200183. doi: 10.1002/pmic.202200183. Epub 2023 May 2.

Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

Lanctôt KL, Chen C, Mah E, Kiss A, Li A, Shade D, Scherer RW, Vieira D, Coulibaly H, Rosenberg PB, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer J, Herrmann N.

Int Psychogeriatr. 2023 Nov;35(11):664-672. doi: 10.1017/S1041610223000327. Epub 2023 Apr 17.

Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee

Vucic S, Stanley Chen KH, Kiernan MC, Hallett M, Benninger DH, Di Lazzaro V, Rossini PM, Benussi A, Berardelli A, Currà A, Krieg SM, Lefaucheur JP, Long Lo Y, Macdonell RA, Massimini M, Rosanova M, Picht T, Stinear CM, Paulus W, Ugawa Y, Ziemann U, Chen R.

Clin Neurophysiol. 2023 Jun;150:131-175. doi: 10.1016/j.clinph.2023.03.010. Epub 2023 Mar 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias